Europe's TEP sector is underdeveloped, says EC
This article was originally published in Clinica
Executive Summary
Commercial tissue engineering is currently concentrated in the "old" EU member states, the so-called EU15, but because of the lack of a single regulatory market and because most products currently available are for autologous use only, there are no tissue engineered products that are available in all 25 EU member states.